acetylgalactosamine has been researched along with Liver Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Akasov, RA; Beloglazkina, EK; Burenina, OY; Erofeev, AS; Evteev, SA; Gorelkin, PV; Ivanenkov, YA; Klyachko, NL; Kovalev, SV; Lobov, AN; Lopatukhina, EV; Lopukhov, AV; Majouga, AG; Naumenko, VA; Pavlova, EN; Ryabaya, OO; Shkil', DO; Skvortsov, DA; Vaneev, AN; Yamansarov, EY | 1 |
| Dong, C; Qian, Z; Shi, K; Tang, L; Tian, Y; Xie, D; Yang, L; Zhang, R; Zhao, B; Zhou, B | 1 |
| Chen, Y; Dong, P; Li, T; Meng, X; Sun, B; Yu, P; Zhu, T | 1 |
| Jian, Q; Li, Z; Liu, X; Shu, J; Yang, Z; Zhang, J | 1 |
| Dhande, YK; Reineke, TM; Tan, Z | 1 |
| Jo, M; Kim, Y; Klein, S; Luo, X; MacLeod, AR; Post, N; Prakash, TP; Schmidt, J; Xiao, X; Yin, Z; Zhou, T | 1 |
| Chevliakov, MV; Durmaz, YY; Elsayed, ME; Ensminger, WD; Medina, SH; Shewach, DS; Stender, RN; Tiruchinapally, G | 1 |
| Gressner, OA | 1 |
| Clausen, H; Higashi, N; Irimura, T; Kanoh, A; Kato, K; Mandel, U; Matsubara, A; Miyahara, N; Morimoto-Tomita, M; Nemoto-Sasaki, Y; Ohashi, Y; Takeuchi, H; Usami, K; Waki, M | 1 |
| Basset, C; Devauchelle, V; Dueymes, M; Durand, V; Jamin, C; Pennec, YL; Youinou, P | 1 |
| Engvall, E; Goldstein, IJ; Hammarström, S; Johansson, BG; Sundblad, G; Svensson, S | 1 |
| Cifonelli, JA; Joung, JI; Levin, B; Rochman, H | 1 |
| Ishizuka, I; Kosaki, G; Yamakawa, T; Yamamoto, T | 1 |
| Barrett, KE | 1 |
| Franz, H; Gabius, HJ; Gabius, S; Joshi, SS; Schirrmacher, V | 1 |
| Ashwell, G; Huber, BE; Steer, CJ; Thorgeirsson, SS; Weiss, P; Wirth, PJ | 1 |
1 review(s) available for acetylgalactosamine and Liver Neoplasms
| Article | Year |
|---|---|
Less Smad2 is good for you! A scientific update on coffee's liver benefits.
Topics: Acetylgalactosamine; Animals; Caffeine; Carcinoma, Hepatocellular; Collagen Type I; Connective Tissue Growth Factor; Humans; Liver; Liver Neoplasms; Proteasome Endopeptidase Complex; Smad2 Protein; Theophylline; Transforming Growth Factor beta; Xanthines | 2009 |
15 other study(ies) available for acetylgalactosamine and Liver Neoplasms
| Article | Year |
|---|---|
Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma.
Topics: Acetylgalactosamine; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Drug Discovery; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Molecular Docking Simulation; Surface Plasmon Resonance; Triterpenes | 2021 |
Sustained and targeted delivery of siRNA/DP7-C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy.
Topics: Acetylgalactosamine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Drug Compounding; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrogels; Injections, Subcutaneous; Liver Neoplasms; Mice; NIMA-Interacting Peptidylprolyl Isomerase; Pore Forming Cytotoxic Proteins; RNA, Small Interfering; Thermodynamics; Xenograft Model Antitumor Assays | 2021 |
N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
Topics: Acetylgalactosamine; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Molecular Structure; Nanoparticles; Paclitaxel; Structure-Activity Relationship | 2021 |
Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Topics: Acetylgalactosamine; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Endoplasmic Reticulum Chaperone BiP; Glycogen Synthase Kinase 3 beta; Heat-Shock Proteins; Humans; Lectins; Liver Neoplasms; Membrane Glycoproteins; Neoplasm Invasiveness; Neoplasm Metastasis; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
Cell Penetrating Polymers Containing Guanidinium Trigger Apoptosis in Human Hepatocellular Carcinoma Cells unless Conjugated to a Targeting N-Acetyl-Galactosamine Block.
Topics: Acetylgalactosamine; Apoptosis; Biological Transport; Carcinoma, Hepatocellular; Cell Survival; Drug Carriers; Guanidine; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Polymerization; Polymers; Transfection | 2017 |
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
Topics: Acetylgalactosamine; Animals; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Gene Expression; Gene Transfer Techniques; Liver Neoplasms; Mice; Oligonucleotides, Antisense | 2019 |
Targeting hepatic cancer cells with pegylated dendrimers displaying N-acetylgalactosamine and SP94 peptide ligands.
Topics: Acetylgalactosamine; Acetylglucosamine; Animals; Antigens, CD7; Cells, Cultured; Dendrimers; Fluorescent Dyes; Half-Life; Hep G2 Cells; Humans; Kupffer Cells; Ligands; Liver; Liver Neoplasms; Mice; Mice, Nude; Particle Size; Peptides; Phagocytosis; Polyethylene Glycols; Rats; Time Factors; Tissue Distribution; Transplantation, Heterologous | 2013 |
Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Topics: Acetylgalactosamine; Amino Acid Sequence; Animals; Antibodies; Cell Line, Tumor; Colonic Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycopeptides; Glycosylation; Humans; Lectins; Liver Neoplasms; Mice; Microsomes; Molecular Sequence Data; Mucins; N-Acetylgalactosaminyltransferases; Polypeptide N-acetylgalactosaminyltransferase; RNA, Messenger; Substrate Specificity | 2010 |
Glycosylation of immunoglobulin A influences its receptor binding.
Topics: Acetylgalactosamine; Acetylglucosamine; Carcinoma, Hepatocellular; Endocytosis; Galactose; Glucose; Glycosylation; Humans; Immunoglobulin A; Liver Neoplasms; N-Acetylneuraminic Acid; Neoplasm Proteins; Neuraminidase; Protein Binding; Protein Processing, Post-Translational; Receptors, Fc; Sialyltransferases; Sjogren's Syndrome; Tumor Cells, Cultured; U937 Cells | 1999 |
Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.
Topics: Acetylgalactosamine; Acetylglucosamine; Animals; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Colonic Neoplasms; Epitopes; Fluorescent Antibody Technique; Fucose; Galactose; Humans; Lectins; Liver; Liver Neoplasms; Mannose; Neoplasm Metastasis; Oligosaccharides; Papain; Precipitin Tests; Rabbits; Radioimmunoassay; Sialic Acids | 1975 |
Preparation of carcinoembryonic antigen (CEA) containing significantly increased amounts of galactose and galactosamine.
Topics: Acetylgalactosamine; Amino Acids; Antigen-Antibody Reactions; Carbohydrates; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chromatography, Agarose; Colonic Neoplasms; Galactosamine; Galactose; Hexosamines; Humans; Immunodiffusion; Liver Neoplasms; Neoplasm Metastasis; Sialic Acids | 1975 |
Heterogeneity of carcinoembryonic antigen. II. Monosaccharide composition of concanavalin A-reactive and -nonreactive CEA.
Topics: Acetylgalactosamine; Acetylglucosamine; Binding Sites; Carcinoembryonic Antigen; Chromatography, Affinity; Concanavalin A; Fucose; Galactose; Glucosamine; Humans; Liver Neoplasms; Mannose; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Rectal Neoplasms; Sialic Acids | 1975 |
Mucus and metastasis.
Topics: Acetylgalactosamine; Animals; Colonic Neoplasms; Disease Models, Animal; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Nude; Mucins | 1992 |
Analysis of cell-surface sugar receptor expression by neoglycoenzyme binding and adhesion to plastic-immobilized neoglycoproteins for related weakly and strongly metastatic cell lines of murine tumor model systems.
Topics: Acetylgalactosamine; Animals; Binding Sites; Carbohydrate Metabolism; Cell Adhesion Molecules; Cell Membrane; Glycoproteins; Glycosylation; Liver Neoplasms; Lung Neoplasms; Mice; Models, Biological; Receptors, Cell Surface; Tumor Cells, Cultured | 1990 |
Ligand-induced modulation of the hepatic receptor for asialoglycoproteins in the human hepatoblastoma cell line, Hep G2.
Topics: Acetylgalactosamine; Asialoglycoprotein Receptor; Asialoglycoproteins; Carcinoma, Hepatocellular; Humans; Kinetics; Ligands; Liver Neoplasms; Molecular Weight; Ornithine Decarboxylase; Orosomucoid; Receptors, Immunologic; Tumor Cells, Cultured | 1987 |